Subtypes of familial breast tumours revealed by expression and copy number profiling

Breast Cancer Research and Treatment

Volumn 123, Issue 3, 2010, Pages 661-677

  Waddell, Nic ^a   Arnold, Jeremy ^a   Cocciardi, Sibylle ^a   Da Silva, Leonard ^b   Marsh, Anna ^a   Riley, Joan ^a,c   Johnstone, Cameron N ^a,d   Orloff, Mohammed ^e   Assie, Guillaume ^e   Eng, Charis ^e   Reid, Lynne ^b   Keith, Patricia ^b   Yan, Max ^d   Fox, Stephen ^d   Devilee, Peter ^f   Godwin, Andrew K ^g   Hogervorst, Frans B L ^h   Couch, Fergus ⁱ   Investigators, Kconfab ^d   Grimmond, Sean ^b   Flanagan, James M ^j   Khanna, Kumkum ^a   Simpson, Peter T ^b   Lakhani, Sunil R ^b   Chenevix Trench, Georgia ^a   more..

^a QIMR BERGHOFER MEDICAL RESEARCH INSTITUTE   (Australia)

^b UNIVERSITY OF QUEENSLAND   (Australia)

^c MRC TOXICOLOGY UNIT   (United Kingdom)

^d PETER MACCALLUM CANCER CENTRE   (Australia)

^e LERNER RESEARCH INSTITUTE   (United States)

^f LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^g FOX CHASE CANCER CENTER   (United States)

^h NETHERLANDS CANCER INSTITUTE   (Netherlands)

ⁱ Mayo Clinic   (United States)

^j UNIVERSITY COLLEGE LONDON   (United Kingdom)

more..

Author keywords

BRCA1 and BRCA2; Copy number aberrations; Familial breast cancer; Gene expression; Molecular subtypes

Indexed keywords

BRCA1 PROTEIN; BRCA2 PROTEIN; BRCA1 PROTEIN, HUMAN; BRCA2 PROTEIN, HUMAN;

ARTICLE; BASAL LIKE BREAST CANCER; BRCA2 GENE; BREAST TUMOR; CHROMOSOME 10Q; CHROMOSOME 12P; CHROMOSOME 1Q; CHROMOSOME 5Q; CHROMOSOME 8Q; CHROMOSOME 9P; CHROMOSOME ABERRATION; COHORT ANALYSIS; COMPARATIVE GENOMIC HYBRIDIZATION; FAMILIAL BREAST TUMOR; FAMILIAL CANCER; GENE DOSAGE; GENE EXPRESSION PROFILING; GENE LOSS; GENE MUTATION; GENETIC GAIN; HUMAN; HUMAN TISSUE; LUMINAL A BREAST TUMOR; LUMINAL B BREAST TUMOR; ONCOGENE; PRIORITY JOURNAL; SINGLE NUCLEOTIDE POLYMORPHISM; TUMOR CLASSIFICATION; TUMOR SUPPRESSOR GENE; CLUSTER ANALYSIS; DNA METHYLATION; DNA MICROARRAY; FEMALE; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; HEREDITY; HETEROZYGOSITY LOSS; METHODOLOGY; PATHOLOGY; PEDIGREE; PROGNOSIS;

BRCA1 PROTEIN; BRCA2 PROTEIN; BREAST NEOPLASMS; CHROMOSOME ABERRATIONS; CLUSTER ANALYSIS; COHORT STUDIES; COMPARATIVE GENOMIC HYBRIDIZATION; DNA METHYLATION; FEMALE; GENE DOSAGE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GENETIC PREDISPOSITION TO DISEASE; HEREDITY; HUMANS; LOSS OF HETEROZYGOSITY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PEDIGREE; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS;

EID: 79952118064     PISSN: 01676806     EISSN: 15737217     Source Type: Journal    
DOI: 10.1007/s10549-009-0653-1     Document Type: Article

References (92)

1. (2004) CHEK2*1100delC and susceptibility to breast cancer: A collaborative analysis involving 10,860 breast cancer cases and 9,065 controls from 10 studies. Am J Hum Genet 74:1175-1182
2. Abd El-Rehim DM, Ball G, Pinder SE, Rakha E, Paish C, Robertson JF et al (2005) High-Throughput protein expression analysis using tissue microarray technology of a large wellcharacterised series identifies biologically distinct classes of breast cancer confirming recent cDNA expression analyses. Int J Cancer 116:340-350 (Pubitemid 40993329)
3. Adelaide J, Finetti P, Bekhouche I, Repellini L, Geneix J, Sircoulomb F et al (2007) Integrated profiling of basal and luminal breast cancers. Cancer Res 67:11565-11575
4. Alvarez S, Diaz-Uriarte R, Osorio A, Barroso A, Melchor L, Paz MF et al (2005) A predictor based on the somatic genomic changes of the BRCA1/BRCA2 breast cancer tumors identifies the non-BRCA1/BRCA2 tumors with BRCA1 promoter hypermethylation. Clin Cancer Res 11:1146-1153 (Pubitemid 40175764)
5. Assie G, LaFramboise T, Platzer P, Bertherat J, Stratakis CA, Eng C (2008) SNP arrays in heterogeneous tissue: highly accurate collection of both germline and somatic genetic information from unpaired single tumor samples. Am J Hum Genet 82:903-915
6. Bane AL, Beck JC, Bleiweiss I, Buys SS, Catalano E, Daly MB et al (2007) BRCA2 mutation-Associated breast cancers exhibit a distinguishing phenotype based on morphology and molecular profiles from tissue microarrays. Am J Surg Pathol 31:121-128 (Pubitemid 46036911)
7. Bane AL, Pinnaduwage D, Colby S, Bull SB, O'Malley FP, Andrulis IL (2009) Expression profiling of familial breast cancers demonstrates higher expression of FGFR2 in BRCA2-Associated tumors. Breast Cancer Res Treat 117:183-191
8. BCLC (1997) Pathology of familial breast cancer: differences between breast cancers in carriers of BRCA1 or BRCA2 mutations and sporadic cases. Lancet 349:1505-1510
9. Beger C, Pierce LN, Kruger M, Marcusson EG, Robbins JM, Welcsh P et al (2001) Identification of Id4 as a regulator of BRCA1 expression by using a ribozyme-library-based inverse genomics approach. Proc Natl Acad Sci USA 98:130-135 (Pubitemid 32095875)
10. Benito M, Parker J, Du Q, Wu J, Xiang D, Perou CM et al (2004) Adjustment of systematic microarray data biases. Bioinformatics 20:105-114 (Pubitemid 38094234)
11. Bergamaschi A, Kim YH, Wang P, Sorlie T, Hernandez-Boussard T, Lonning PE et al (2006) Distinct patterns of DNA copy number alteration are associated with different clinicopathological features and gene-expression subtypes of breast cancer. Genes Chromosomes Cancer 45:1033-1040 (Pubitemid 44435537)
12. Bianco T, Chenevix-Trench G, Walsh DC, Cooper JE, Dobrovic A (2000) Tumour-specific distribution of BRCA1 promoter region methylation supports a pathogenetic role in breast and ovarian cancer. Carcinogenesis 21:147-151 (Pubitemid 30098695)
13. Birgisdottir V, Stefansson OA, Bodvarsdottir SK, Hilmarsdottir H, Jonasson JG, Eyfjord JE (2006) Epigenetic silencing and deletion of the BRCA1 gene in sporadic breast cancer. Breast Cancer Res 8:R38
14. Budroni M, Cesaraccio R, Coviello V, Sechi O, Pirino D, Cossu A et al (2009) Role of BRCA2 mutation status on overall survival among breast cancer patients from Sardinia. BMC Cancer 9:62
15. Carter SL, Eklund AC, Kohane IS, Harris LN, Szallasi Z (2006) A signature of chromosomal instability inferred from gene expression profiles predicts clinical outcome in multiple human cancers. Nat Genet 38:1043-1048 (Pubitemid 44325930)
16. Catteau A, Harris WH, Xu CF, Solomon E (1999) Methylation of the BRCA1 promoter region in sporadic breast and ovarian cancer: correlation with disease characteristics. Oncogene 18:1957-1965 (Pubitemid 29150082)
17. Chin K, DeVries S, Fridlyand J, Spellman PT, Roydasgupta R, Kuo WL et al (2006) Genomic and transcriptional aberrations linked to breast cancer pathophysiologies. Cancer Cell 10:529-541 (Pubitemid 44854748)
18. Claus EB, Schildkraut JM, Thompson WD, Risch NJ (1996) The genetic attributable risk of breast and ovarian cancer. Cancer 77:2318-2324 (Pubitemid 26162426)
19. Colella S, Yau C, Taylor JM, Mirza G, Butler H, Clouston P et al (2007) QuantiSNP: An Objective Bayes Hidden-Markov Model to detect and accurately map copy number variation using SNP genotyping data. Nucleic Acids Res 35:2013-2025 (Pubitemid 47061667)
20. Colombo M, Giarola M, Mariani L, Ripamonti CB, De Benedetti V, Sardella M et al. (2008) Cyclin D1 expression analysis in familial breast cancers may discriminate BRCAX from BRCA2-linked cases. Mod Pathol 21:1262-1270
21. Cox A, Dunning AM, Garcia-Closas M, Balasubramanian S, Reed MW, Pooley KA et al (2007) A common coding variant in CASP8 is associated with breast cancer risk. Nat Genet 39:352-358 (Pubitemid 46328496)
22. Du P, Kibbe WA, Lin SM (2008) lumi: A pipeline for processing Illumina microarray. Bioinformatics 24:1547-1548 (Pubitemid 351911712)
23. Dworkin AM, Spearman AD, Tseng SY, Sweet K, Toland AE (2009). Methylation not a frequent ''second hit'' in tumors with germline BRCA mutations. Fam Cancer 8:339-346
24. Easton DF, Pooley KA, Dunning AM, Pharoah PD, Thompson D, Ballinger DG et al (2007) Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447: 1087-1093 (Pubitemid 47014426)
25. Edwards SL, Brough R, Lord CJ, Natrajan R, Vatcheva R, Levine DA et al (2008) Resistance to therapy caused by intragenic deletion in BRCA2. Nature 451:1111-1115 (Pubitemid 351317441)
26. Engelman JA, Luo J, Cantley LC (2006) The evolution of phosphatidylinositol 3-kinases as regulators of growth and metabolism. Nat Rev Genet 7:606-619 (Pubitemid 44100518)
27. Esteller M, Silva JM, Dominguez G, Bonilla F, Matias-Guiu X, Lerma E et al (2000) Promoter hypermethylation and BRCA1 inactivation in sporadic breast and ovarian tumors. J Natl Cancer Inst 92:564-569 (Pubitemid 30212318)
28. Fong PC, Boss DS, Yap TA, Tutt A, Wu P, Mergui-Roelvink M et al (2009) Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers. N Engl J Med 361:123-134
29. Foulkes WD, Stefansson IM, Chappuis PO, Begin LR, Goffin JR, Wong N et al (2003) Germline BRCA1 mutations and a basal epithelial phenotype in breast cancer. J Natl Cancer Inst 95:1482-1485 (Pubitemid 37279334)
30. Gronwald J, Jauch A, Cybulski C, Schoell B, Bohm-Steuer B, Lener M et al (2005) Comparison of genomic abnormalities between BRCAX and sporadic breast cancers studied by comparative genomic hybridization. Int J Cancer 114:230-236 (Pubitemid 40194291)
31. Harris LN, You F, Schnitt SJ, Witkiewicz A, Lu X, Sgroi D et al (2007) Predictors of resistance to preoperative trastuzumab and vinorelbine for HER2-positive early breast cancer. Clin Cancer Res 13:1198-1207 (Pubitemid 46424061)
32. Haverty PM, Fridlyand J, Li L, Getz G, Beroukhim R, Lohr S et al (2008) High-resolution genomic and expression analyses of copy number alterations in breast tumors. Genes Chromosomes Cancer 47:530-542 (Pubitemid 351657188)
33. Hedenfalk I, Duggan D, Chen Y, Radmacher M, Bittner M, Simon R et al (2001) Gene-expression profiles in hereditary breast cancer. N Engl J Med 344:539-548 (Pubitemid 32167867)
34. Hedenfalk I, Ringner M, Ben-Dor A, Yakhini Z, Chen Y, Chebil G et al (2003) Molecular classification of familial non-BRCA1/BRCA2 breast cancer. Proc Natl Acad Sci USA 100: 2532-2537 (Pubitemid 36297533)
35. Hollestelle A, Nagel JH, Smid M, Lam S, Elstrodt F, Wasielewski M et al. (2009). Distinct gene mutation profiles among luminal-Type and basal-Type breast cancer cell lines. Breast Cancer Res Treat. doi:10.1007/s10549-009-0460-8
36. Honrado E, Benitez J, Palacios J (2006) Histopathology of BRCA1-And BRCA2-Associated breast cancer. Crit Rev Oncol Hematol 59:27-39 (Pubitemid 43903277)
37. Honrado E, Osorio A, Milne RL, Paz MF, Melchor L, Cascon A et al (2007) Immunohistochemical classification of non-BRCA1/2 tumors identifies different groups that demonstrate the heterogeneity of BRCAX families. Mod Pathol 20:1298-1306 (Pubitemid 350126855)
38. Honrado E, Osorio A, Palacios J, Milne RL, Sanchez L, Diez O et al (2005) Immunohistochemical expression of DNA repair proteins in familial breast cancer differentiate BRCA2-Associated tumors. J Clin Oncol 23:7503-7511 (Pubitemid 46291813)
39. Hu Z, Fan C, Oh DS, Marron JS, He X, Qaqish BF et al (2006) The molecular portraits of breast tumors are conserved across microarray platforms. BMC Genomics 7:96
40. Hu X, Stern HM, Ge L, O'Brien C, Haydu L, Honchell CD et al (2009) Genetic alterations and oncogenic pathways associated with breast cancer subtypes. Mol Cancer Res 7:511-522
41. Jacquemier J, Ginestier C, Rougemont J, Bardou VJ, Charafe-Jauffret E, Geneix J et al (2005) Protein expression profiling identifies subclasses of breast cancer and predicts prognosis. Cancer Res 65:767-779 (Pubitemid 40216434)
42. Jonsson G, Naylor TL, Vallon-Christersson J, Staaf J, Huang J, Ward MR et al (2005) Distinct genomic profiles in hereditary breast tumors identified by array-based comparative genomic hybridization. Cancer Res 65:7612-7621 (Pubitemid 41297233)
43. Joosse SA, van Beers EH, Tielen IH, Horlings H, Peterse JL, Hoogerbrugge N et al (2009) Prediction of BRCA1-Association in hereditary non-BRCA1/2 breast carcinomas with array-CGH. Breast Cancer Res Treat 116:479-489
44. Kauraniemi P, Hedenfalk I, Persson K, Duggan DJ, Tanner M, Johannsson O et al (2000) MYB oncogene amplification in hereditary BRCA1 breast cancer. Cancer Res 60:5323-5328
45. Kreike B, van Kouwenhove M, Horlings H, Weigelt B, Peterse H, Bartelink H et al (2007) Gene expression profiling and histopathological characterization of triple-negative/basal-like breast carcinomas. Breast Cancer Res 9:R65
46. Lakhani SR, Jacquemier J, Sloane JP, Gusterson BA, Anderson TJ, van de Vijver MJ et al (1998) Multifactorial analysis of differences between sporadic breast cancers and cancers involving BRCA1 and BRCA2 mutations. J Natl Cancer Inst 90:1138-1145 (Pubitemid 28380718)
47. Lakhani SR, Van De Vijver MJ, Jacquemier J, Anderson TJ, Osin PP, McGuffog L et al (2002) The pathology of familial breast cancer: predictive value of immunohistochemical markers estrogen receptor, progesterone receptor, HER-2, and p53 in patients with mutations in BRCA1 and BRCA2. J Clin Oncol 20:2310-2318 (Pubitemid 34441658)
48. Lakhani SR, Reis-Filho JS, Fulford L, Penault-Llorca F, van der Vijver M, Parry S et al (2005) Prediction of BRCA1 status in patients with breast cancer using estrogen receptor and basal phenotype. Clin Cancer Res 11:5175-5180 (Pubitemid 41003703)
49. Lingjaerde OC, Baumbusch LO, Liestol K, Glad IK, Borresen-Dale AL (2005) CGH-Explorer: A program for analysis of array-CGH data. Bioinformatics 21:821-822 (Pubitemid 40439420)
50. Mackay A, Tamber N, Fenwick K, Iravani M, Grigoriadis A, Dexter T et al (2009) A high-resolution integrated analysis of genetic and expression profiles of breast cancer cell lines. Breast Cancer Res Treat 118:481-498
51. Mann GJ, Thorne H, Balleine RL, Butow PN, Clarke CL, Edkins E et al (2006) Analysis of cancer risk and BRCA1 and BRCA2 mutation prevalence in the kConFab familial breast cancer resource. Breast Cancer Res 8:R12
52. Marcus JN, Watson P, Page DL, Narod SA, Tonin P, Lenoir GM et al (1997) BRCA2 hereditary breast cancer pathophenotype. Breast Cancer Res Treat 44:275-277 (Pubitemid 27296388)
53. Martin RW, Orelli BJ, Yamazoe M, Minn AJ, Takeda S, Bishop DK (2007) RAD51 up-regulation bypasses BRCA1 function and is a common feature of BRCA1-deficient breast tumors. Cancer Res 67:9658-9665 (Pubitemid 47621212)
54. Marty B, Maire V, Gravier E, Rigaill G, Vincent-Salomon A, Kappler M et al (2008) Frequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cells. Breast Cancer Res 10:R101
55. Matros E, Wang ZC, Lodeiro G, Miron A, Iglehart JD, Richardson AL (2005) BRCA1 promoter methylation in sporadic breast tumors: relationship to gene expression profiles. Breast Cancer Res Treat 91:179-186 (Pubitemid 40684930)
56. Matsuda M, Miyagawa K, Takahashi M, Fukuda T, Kataoka T, Asahara T et al (1999) Mutations in the RAD54 recombination gene in primary cancers. Oncogene 18:3427-3430 (Pubitemid 29286990)
57. Melchor L, Benitez J (2008) An integrative hypothesis about the origin and development of sporadic and familial breast cancer subtypes. Carcinogenesis 29:1475-1482
58. Melchor L, Honrado E, Garcia MJ, Alvarez S, Palacios J, Osorio A et al. (2008) Distinct genomic aberration patterns are found in familial breast cancer associated with different immunohistochemical subtypes. Oncogene 27:3165-3175 (Pubitemid 351693170)
59. Natrajan R, Lambros MB, Rodriguez-Pinilla SM, Moreno-Bueno G, Tan DS, Marchio C et al (2009) Tiling path genomic profiling of grade 3 invasive ductal breast cancers. Clin Cancer Res 15:2711-2722
60. Nielsen TO, Hsu FD, Jensen K, Cheang M, Karaca G, Hu Z et al (2004) Immunohistochemical and clinical characterization of the basal-like subtype of invasive breast carcinoma. Clin Cancer Res 10:5367-5374 (Pubitemid 39100473)
61. Nordgard SH, Johansen FE, Alnaes GI, Bucher E, Syvanen AC, Naume B et al (2008) Genome-wide analysis identifies 16q deletion associated with survival, molecular subtypes, mRNA expression, and germline haplotypes in breast cancer patients. Genes Chromosomes Cancer 47:680-696 (Pubitemid 351847581)
62. Oldenburg RA, Kroeze-Jansema K, Meijers-Heijboer H, van Asperen CJ, Hoogerbrugge N, van Leeuwen I et al (2006) Characterization of familial non-BRCA1/2 breast tumors by loss of heterozygosity and immunophenotyping. Clin Cancer Res 12:1693-1700
63. Palacios J, Honrado E, Osorio A, Cazorla A, Sarrio D, Barroso A et al (2003) Immunohistochemical characteristics defined by tissue microarray of hereditary breast cancer not attributable to BRCA1 or BRCA2 mutations: differences from breast carcinomas arising in BRCA1 and BRCA2 mutation carriers. Clin Cancer Res 9:3606-3614 (Pubitemid 37169224)
64. Palacios J, Honrado E, Osorio A, Cazorla A, Sarrio D, Barroso A et al (2005) Phenotypic characterization of BRCA1 and BRCA2 tumors based in a tissue microarray study with 37 immunohistochemical markers. Breast Cancer Res Treat 90:5-14 (Pubitemid 40486996)
65. Perou CM, Jeffrey SS, van de Rijn M, Rees CA, Eisen MB, Ross DT et al (1999) Distinctive gene expression patterns in human mammary epithelial cells and breast cancers. Proc Natl Acad Sci USA 96:9212-9217 (Pubitemid 29374734)
66. Perou CM, Sorlie T, Eisen MB, van de Rijn M, Jeffrey SS, Rees CA et al (2000) Molecular portraits of human breast tumours. Nature 406:747-752
67. Radpour R, Kohler C, Haghighi MM, Fan AX, Holzgreve W, Zhong XY (2009). Methylation profiles of 22 candidate genes in breast cancer using high-Throughput MALDI-TOF mass array. Oncogene 28:2969-2978
68. Rauta J, Alarmo EL, Kauraniemi P, Karhu R, Kuukasjarvi T, Kallioniemi A (2006) The serine-Threonine protein phosphatase PPM1D is frequently activated through amplification in aggressive primary breast tumours. Breast Cancer Res Treat 95:257-263
69. Rayter S, Elliott R, Travers J, Rowlands MG, Richardson TB, Boxall K et al (2008) A chemical inhibitor of PPM1D that selectively kills cells overexpressing PPM1D. Oncogene 27:1036-1044 (Pubitemid 351253192)
70. Saal LH, Gruvberger-Saal SK, Persson C, Lovgren K, Jumppanen M, Staaf J et al (2008) Recurrent gross mutations of the PTEN tumor suppressor gene in breast cancers with deficient DSB repair. Nat Genet 40:102-107
71. Shih HA, Couch FJ, Nathanson KL, Blackwood MA, Rebbeck TR, Armstrong KA et al (2002) BRCA1 and BRCA2 mutation frequency in women evaluated in a breast cancer risk evaluation clinic. J Clin Oncol 20:994-999 (Pubitemid 34141843)
72. Smyth GK (2004). Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 3:Article3
73. Smyth GK (2005) Limma: linear models for microarray data. Springer, New York, pp 397-420
74. Sorlie T (2004) Molecular portraits of breast cancer: tumour subtypes as distinct disease entities. Eur J Cancer 40:2667-2675 (Pubitemid 39574720)
75. Sorlie T, Perou CM, Tibshirani R, Aas T, Geisler S, Johnsen H et al (2001) Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications. Proc Natl Acad Sci USA 98:10869-10874 (Pubitemid 32878711)
76. Sorlie T, Tibshirani R, Parker J, Hastie T, Marron JS, Nobel A et al (2003) Repeated observation of breast tumor subtypes in independent gene expression data sets. Proc Natl Acad Sci USA 100:8418-8423 (Pubitemid 36842560)
77. Sorlie T, Wang Y, Xiao C, Johnsen H, Naume B, Samaha RR et al (2006) Distinct molecular mechanisms underlying clinically relevant subtypes of breast cancer: gene expression analyses across three different platforms. BMC Genomics 7:127
78. Sotiriou C, Neo SY, McShane LM, Korn EL, Long PM, Jazaeri A et al (2003) Breast cancer classification and prognosis based on gene expression profiles from a population-based study. Proc Natl Acad Sci USA 100:10393-10398 (Pubitemid 37071889)
79. Stefansson OA, Jonasson JG, Johannsson OT, Olafsdottir K, Steinarsdottir M, Valgeirsdottir S et al (2009) Genomic profiling of breast tumours in relation to BRCA abnormalities and phenotypes. Breast Cancer Res 11:R47
80. Tavtigian SV, Oefner PJ, Babikyan D, Hartmann A, Healey S, Le Calvez-Kelm F et al. (2009) Rare evolutionarily unlikely missense substitutions in ATM confer increased risk of breast cancer. Am J Hum Genet 85:427-446
81. Tibshirani R, Hastie T, Narasimhan B, Chu G (2002) Diagnosis of multiple cancer types by shrunken centroids of gene expression. Proc Natl Acad Sci USA 99:6567-6572 (Pubitemid 34526173)
82. Tirkkonen M, Johannsson O, Agnarsson BA, Olsson H, Ingvarsson S, Karhu R et al (1997) Distinct somatic genetic changes associated with tumor progression in carriers of BRCA1 and BRCA2 germ-line mutations. Cancer Res 57:1222-1227 (Pubitemid 27152540)
83. Tischkowitz M, Xia B, Sabbaghian N, Reis-Filho JS, Hamel N, Li G et al (2007) Analysis of PALB2/FANCN-Associated breast cancer families. Proc Natl Acad Sci USA 104:6788-6793 (Pubitemid 47175579)
84. Turner NC, Reis-Filho JS, Russell AM, Springall RJ, Ryder K, Steele D et al (2007) BRCA1 dysfunction in sporadic basal-like breast cancer. Oncogene 26:2126-2132 (Pubitemid 46514749)
85. van't Veer LJ, Dai H, van de Vijver MJ, He YD, Hart AA, Mao M et al (2002) Gene expression profiling predicts clinical outcome of breast cancer. Nature 415:530-536 (Pubitemid 34130608)
86. van Beers EH, van Welsem T, Wessels LF, Li Y, Oldenburg RA, Devilee P et al (2005) Comparative genomic hybridization profiles in human BRCA1 and BRCA2 breast tumors highlight differential sets of genomic aberrations. Cancer Res 65:822-827 (Pubitemid 40216440)
87. Vincent-Salomon A, Gruel N, Lucchesi C, MacGrogan G, Dendale R, Sigal-Zafrani B et al (2007) Identification of typical medullary breast carcinoma as a genomic sub-group of basal-like carcinomas, a heterogeneous new molecular entity. Breast Cancer Res 9:R24
88. Wang K, Li M, Hadley D, Liu R, Glessner J, Grant SF et al (2007) PennCNV: An integrated hidden Markov model designed for high-resolution copy number variation detection in wholegenome SNP genotyping data. Genome Res 17:1665-1674 (Pubitemid 350074862)
89. Weber F, Shen L, Fukino K, Patocs A, Mutter GL, Caldes T et al (2006) Total-genome analysis of BRCA1/2-related invasive carcinomas of the breast identifies tumor stroma as potential landscaper for neoplastic initiation. Am J Hum Genet 78:961-972 (Pubitemid 43787688)
90. Wei M, Grushko TA, Dignam J, Hagos F, Nanda R, Sveen L et al (2005) BRCA1 promoter methylation in sporadic breast cancer is associated with reduced BRCA1 copy number and chromosome 17 aneusomy. Cancer Res 65:10692-10699 (Pubitemid 41713336)
91. Wessels LF, van Welsem T, Hart AA, van't Veer LJ, Reinders MJ, Nederlof PM (2002) Molecular classification of breast carcinomas by comparative genomic hybridization: A specific somatic genetic profile for BRCA1 tumors. Cancer Res 62:7110-7117 (Pubitemid 35424107)
92. Yan M, kConFab Investigators, Fox SB (2009) Does cyclin D1 discriminate between BRCA2 and BRCAx breast cancers? Histolopathology 55:625-626